It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
The overlooked victims of COVID-19: The children

Commentary / World Oct 24, 2021

The overlooked victims of COVID-19: The children

by Cesar Chelala

The isolation measures imposed by the pandemic have severely curtailed social development in children, resulting in a wide array of mental, emotional and behavioral health issues.

A dangerous global divide on vaccine access

Commentary / World Oct 24, 2021

A dangerous global divide on vaccine access

by Mark Malloch-Brown, Raj Shah and Darren Walker

The inequitable vaccine divide leaves humanity far more vulnerable to the next stage of the pandemic, as well as to any other systemic crisis that may emerge.

Benefits of Pfizer child shot likely outweigh risks, FDA says

World Oct 23, 2021

Benefits of Pfizer child shot likely outweigh risks, FDA says

Clearing a vaccine for elementary-school age children would mark a major milestone in the pandemic.

Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19

National | EXPLAINER Oct 20, 2021

Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19

by Osamu Tsukimori

The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.

What scientists know about the risk of breakthrough COVID-19 deaths

World / Science & Health Oct 19, 2021

What scientists know about the risk of breakthrough COVID-19 deaths

by Emily Anthes

After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people

World Oct 15, 2021

U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people

If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.

Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind

World Oct 14, 2021

Rush to buy Merck’s COVID-19 pill risks leaving poor countries behind

by James Paton

Despite efforts to license molnupiravir to generic-drug firms, the same risks of unequal distribution remain, says report.

Why some nations using the same vaccines have deadlier COVID-19 outbreaks

World | FOCUS Oct 13, 2021

Why some nations using the same vaccines have deadlier COVID-19 outbreaks

by Jinshan Hong, Lisa Du and Yasufumi Saito

Everything from dose intervals to the behavior of unvaccinated people has shaped the outcome of recent delta-driven waves in different countries.

AstraZeneca drug effective at treating mild COVID-19 symptoms in trial

World Oct 11, 2021

AstraZeneca drug effective at treating mild COVID-19 symptoms in trial

by Suzi Ring

The antibody cocktail from AstraZeneca may offer a simple way of treating patients before they ever visit the hospital.

Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor

World Oct 11, 2021

Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor

by Rebecca Robbins

Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

World Oct 8, 2021

Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11

The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.

COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says

Business / Corporate Oct 8, 2021

COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says

by Lisa Du and Kanako Matsuyama

Competition to snag a piece of the COVID pill market is fierce, as the world adjusts to the virus being endemic.

« 1 … 23 24 25 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times